Reynders McVeigh Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.46M | Sell |
9,072
-118
| -1% | -$64K | 0.23% | 60 |
|
|
2025
Q4 | $5.33M | Sell |
9,190
-201
| -2% | -$114K | 0.25% | 59 |
|
|
2025
Q3 | $4.55M | Sell |
9,391
-319
| -3% | -$148K | 0.21% | 62 |
|
|
2025
Q2 | $3.94M | Buy |
9,710
+45
| +0.5% | +$18.8K | 0.2% | 64 |
|
|
2025
Q1 | $4.81M | Sell |
9,665
-816
| -8% | -$442K | 0.27% | 56 |
|
|
2024
Q4 | $5.45M | Sell |
10,481
-73
| -0.7% | -$40.1K | 0.29% | 55 |
|
|
2024
Q3 | $6.53M | Buy |
10,554
+111
| +1% | +$65.7K | 0.35% | 50 |
|
|
2024
Q2 | $5.78M | Buy |
10,443
+165
| +2% | +$94.5K | 0.33% | 51 |
|
|
2024
Q1 | $5.97M | Sell |
10,278
-171
| -2% | -$96K | 0.34% | 54 |
|
|
2023
Q4 | $5.55M | Sell |
10,449
-735
| -7% | -$356K | 0.35% | 54 |
|
|
2023
Q3 | $5.66M | Sell |
11,184
-115
| -1% | -$61.3K | 0.39% | 46 |
|
|
2023
Q2 | $5.89M | Sell |
11,299
-119
| -1% | -$64.2K | 0.39% | 46 |
|
|
2023
Q1 | $6.58M | Sell |
11,418
-264
| -2% | -$149K | 0.45% | 44 |
|
|
2022
Q4 | $6.43M | Sell |
11,682
-216
| -2% | -$114K | 0.47% | 45 |
|
|
2022
Q3 | $6.04M | Sell |
11,898
-232
| -2% | -$130K | 0.47% | 46 |
|
|
2022
Q2 | $6.59M | Sell |
12,130
-181
| -1% | -$99.6K | 0.49% | 46 |
|
|
2022
Q1 | $7.27M | Sell |
12,311
-263
| -2% | -$151K | 0.44% | 45 |
|
|
2021
Q4 | $8.39M | Sell |
12,574
-142
| -1% | -$88.7K | 0.48% | 44 |
|
|
2021
Q3 | $7.26M | Buy |
12,716
+189
| +2% | +$104K | 0.44% | 45 |
|
|
2021
Q2 | $6.32M | Sell |
12,527
-297
| -2% | -$140K | 0.39% | 47 |
|
|
2021
Q1 | $5.85M | Sell |
12,824
-286
| -2% | -$137K | 0.39% | 45 |
|
|
2020
Q4 | $6.11M | Sell |
13,110
-14
| -0.1% | -$6.56K | 0.42% | 44 |
|
|
2020
Q3 | $5.79M | Sell |
13,124
-423
| -3% | -$175K | 0.45% | 45 |
|
|
2020
Q2 | $4.91M | Buy |
13,547
+345
| +3% | +$116K | 0.43% | 45 |
|
|
2020
Q1 | $3.74M | Sell |
13,202
-268
| -2% | -$84.5K | 0.43% | 44 |
|
|
2019
Q4 | $4.38M | Sell |
13,470
-495
| -4% | -$150K | 0.42% | 46 |
|
|
2019
Q3 | $4.07M | Sell |
13,965
-50
| -0.4% | -$14.3K | 0.43% | 45 |
|
|
2019
Q2 | $4.12M | Buy |
14,015
+165
| +1% | +$45.4K | 0.44% | 44 |
|
|
2019
Q1 | $3.79M | Sell |
13,850
-185
| -1% | -$46K | 0.42% | 44 |
|
|
2018
Q4 | $3.14M | Sell |
14,035
-205
| -1% | -$48.1K | 0.42% | 49 |
|
|
2018
Q3 | $3.48M | Sell |
14,240
-47
| -0.3% | -$10.8K | 0.41% | 50 |
|
|
2018
Q2 | $2.96M | Buy |
14,287
+29
| +0.2% | +$6.16K | 0.38% | 53 |
|
|
2018
Q1 | $2.94M | Sell |
14,258
-58
| -0.4% | -$12.2K | 0.37% | 50 |
|
|
2017
Q4 | $2.72M | Sell |
14,316
-11
| -0.1% | -$2.11K | 0.36% | 53 |
|
|
2017
Q3 | $2.71M | Sell |
14,327
-25
| -0.2% | -$4.53K | 0.35% | 55 |
|
|
2017
Q2 | $2.5M | Sell |
14,352
-225
| -2% | -$37.8K | 0.34% | 62 |
|
|
2017
Q1 | $2.24M | Buy |
14,577
+925
| +7% | +$141K | 0.31% | 66 |
|
|
2016
Q4 | $1.93M | Buy |
13,652
+355
| +3% | +$52.3K | 0.27% | 69 |
|
|
2016
Q3 | $2.12M | Sell |
13,297
-545
| -4% | -$84K | 0.31% | 61 |
|
|
2016
Q2 | $2.04M | Buy |
13,842
+2,310
| +20% | +$341K | 0.3% | 66 |
|
|
2016
Q1 | $1.63M | Buy |
11,532
+509
| +5% | +$68.2K | 0.24% | 77 |
|
|
2015
Q4 | $1.56M | Buy |
11,023
+98
| +0.9% | +$13.1K | 0.26% | 66 |
|
|
2015
Q3 | $1.34M | Sell |
10,925
-152
| -1% | -$19.8K | 0.23% | 73 |
|
|
2015
Q2 | $1.44M | Buy |
11,077
+1,215
| +12% | +$158K | 0.23% | 67 |
|
|
2015
Q1 | $1.32M | Sell |
9,862
-949
| -9% | -$122K | 0.23% | 73 |
|
|
2014
Q4 | $1.35M | Buy |
10,811
+290
| +3% | +$35.3K | 0.24% | 73 |
|
|
2014
Q3 | $1.28M | Hold |
10,521
| – | – | 0.24% | 71 |
|
|
2014
Q2 | $1.24M | Buy |
10,521
+125
| +1% | +$14.7K | 0.28% | 68 |
|
|
2014
Q1 | $1.25M | Sell |
10,396
-25
| -0.2% | -$2.97K | 0.3% | 65 |
|
|
2013
Q4 | $1.16M | Buy |
10,421
+16
| +0.2% | +$1.59K | 0.29% | 68 |
|
|
2013
Q3 | $959K | Hold |
10,405
| – | – | 0.27% | 72 |
|
|
2013
Q2 | $881K | Buy |
+10,405
| New | +$866K | 0.26% | 72 |
|
Other funds holding TMO
VCM
Reynders McVeigh Capital Management's TMO Position: Q1 2026 in Review
Reynders McVeigh Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 1.3% in Q1 2026, selling an estimated $64K and leaving 9,072 shares worth $4.46M. The position accounts for 0.23% of the portfolio, ranked #60.
Reynders McVeigh Capital Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.39M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Reynders McVeigh Capital Management held 9,072 shares of Thermo Fisher Scientific worth $4.46M as of Q1 2026.
- Reynders McVeigh Capital Management sold 118 Thermo Fisher Scientific shares in Q1 2026, an estimated $64K.
- Thermo Fisher Scientific made up 0.23% of Reynders McVeigh Capital Management's portfolio in Q1 2026, its #60 holding.
- Reynders McVeigh Capital Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Reynders McVeigh Capital Management's Thermo Fisher Scientific position peaked at $8.39M in Q4 2021.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Reynders McVeigh Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.